The Veterinary Micro‑fibre Endoscope segmentation by application delineates four primary sub‑categories that collectively drive market revenue. Diagnostic endoscopes, employed for internal organ imaging and early disease detection, represent the largest share, accounting for roughly 45 % of total sales due to their widespread use across small‑animal practices and livestock health programs. Surgical endoscopes, which facilitate minimally invasive procedures such as guided biopsies and laparoscopic interventions, contribute an estimated 35 % of the market, reflecting growing adoption of precision surgery in veterinary clinics. Therapeutic devices, used for targeted laser delivery, fluid irrigation, and localized drug administration, hold a 15 % share, supported by expanding treatment protocols for chronic conditions. Finally, Research endoscopes, designed for experimental animal models and pre‑clinical studies, occupy the remaining 5 % of revenue, driven by academic and pharmaceutical research funding. The proportional weighting of these application segments directly influences equipment manufacturing priorities, pricing strategies, and after‑sales service allocation within the overall market.